Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (3275)	4/2/2001 7:36:47 AM
From: nigel bates	of 52153

IMW, the only way out is CONSOLIDATION. COMBINE, instead COMPITING. What is SYMPLE than this? If this fail in next two years, many today sector investors will come short. Because very few have ability to select winners, and even than they are +50% wrong. Prime candidates for adopting this approach are the cash rich genomics companies (eg INCY) who are talking about developing their own drugs. They would be far better served acquiring or merging with someone else. As MZ points out, there far too many disparate efforts as it is. It would be nice to create another two or three Millenniums (? Millennia) nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next